Kwang Dong Pharmaceutical Co., Ltd.

KOSE:A009290 Stok Raporu

Piyasa değeri: ₩221.6b

Kwang Dong Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Kwang Dong Pharmaceutical yıllık ortalama 4.1% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 11.7% annual. Gelirler growing yılda ortalama 5.8% oranında artmaktadır. Kwang Dong Pharmaceutical'in özkaynak karlılığı 5.9% ve net marjı 2.1%'dir.

Anahtar bilgiler

4.1%

Kazanç büyüme oranı

3.8%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi11.3%
Gelir büyüme oranı5.8%
Özkaynak getirisi5.9%
Net Marj2.1%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Kwang Dong Pharmaceutical's (KRX:009290) Solid Profits Have Weak Fundamentals

Mar 25
Kwang Dong Pharmaceutical's (KRX:009290) Solid Profits Have Weak Fundamentals

Is There More To The Story Than Kwang Dong Pharmaceutical's (KRX:009290) Earnings Growth?

Dec 04
Is There More To The Story Than Kwang Dong Pharmaceutical's (KRX:009290) Earnings Growth?

Recent updates

There Is A Reason Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Undemanding

Aug 06
There Is A Reason Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Undemanding

Kwang Dong Pharmaceutical's (KRX:009290) Solid Profits Have Weak Fundamentals

Mar 25
Kwang Dong Pharmaceutical's (KRX:009290) Solid Profits Have Weak Fundamentals

Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Right But Growth Is Lacking

Mar 20
Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Right But Growth Is Lacking

Is Kwang Dong Pharmaceutical (KRX:009290) Using Too Much Debt?

Apr 29
Is Kwang Dong Pharmaceutical (KRX:009290) Using Too Much Debt?

Is Now The Time To Put Kwang Dong Pharmaceutical (KRX:009290) On Your Watchlist?

Apr 06
Is Now The Time To Put Kwang Dong Pharmaceutical (KRX:009290) On Your Watchlist?

Did Business Growth Power Kwang Dong Pharmaceutical's (KRX:009290) Share Price Gain of 117%?

Mar 18
Did Business Growth Power Kwang Dong Pharmaceutical's (KRX:009290) Share Price Gain of 117%?

Is Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Popular Amongst Insiders?

Mar 01
Is Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Popular Amongst Insiders?

Should Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Be Part Of Your Dividend Portfolio?

Feb 14
Should Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Be Part Of Your Dividend Portfolio?

Estimating The Fair Value Of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Feb 01
Estimating The Fair Value Of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Kwang Dong Pharmaceutical (KRX:009290) Seems To Use Debt Quite Sensibly

Jan 19
Kwang Dong Pharmaceutical (KRX:009290) Seems To Use Debt Quite Sensibly

If You Like EPS Growth Then Check Out Kwang Dong Pharmaceutical (KRX:009290) Before It's Too Late

Jan 06
If You Like EPS Growth Then Check Out Kwang Dong Pharmaceutical (KRX:009290) Before It's Too Late

Here's What We Like About Kwang Dong Pharmaceutical's (KRX:009290) Upcoming Dividend

Dec 24
Here's What We Like About Kwang Dong Pharmaceutical's (KRX:009290) Upcoming Dividend

Can You Imagine How Kwang Dong Pharmaceutical's (KRX:009290) Shareholders Feel About The 54% Share Price Increase?

Dec 18
Can You Imagine How Kwang Dong Pharmaceutical's (KRX:009290) Shareholders Feel About The 54% Share Price Increase?

Is There More To The Story Than Kwang Dong Pharmaceutical's (KRX:009290) Earnings Growth?

Dec 04
Is There More To The Story Than Kwang Dong Pharmaceutical's (KRX:009290) Earnings Growth?

What Type Of Shareholders Own The Most Number of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Shares?

Nov 21
What Type Of Shareholders Own The Most Number of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Shares?

Gelir ve Gider Dağılımı

Kwang Dong Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

KOSE:A009290 Gelir, gider ve kazançlar (KRW Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 241,607,44433,887244,96813,942
31 Mar 241,569,99141,121240,26213,816
31 Dec 231,514,45436,966233,84815,275
30 Sep 231,509,98138,578232,56611,458
30 Jun 231,489,79336,189232,63811,757
31 Mar 231,476,24830,631228,27011,346
31 Dec 221,431,54524,174225,6469,678
30 Sep 221,412,47823,615222,6689,416
30 Jun 221,385,26426,115214,2829,013
31 Mar 221,356,28725,453212,9868,383
31 Dec 211,338,18224,019212,9618,322
30 Sep 211,282,05610,642205,5526,955
30 Jun 211,247,49632,216201,9936,401
31 Mar 211,237,24040,840197,8406,855
31 Dec 201,243,77045,370195,6785,957
30 Sep 201,256,38854,621200,9635,704
30 Jun 201,244,06428,203203,1725,830
31 Mar 201,244,96324,627201,9865,164
31 Dec 191,238,25523,058199,9165,339
30 Sep 191,215,66722,304193,4175,967
30 Jun 191,224,38626,756189,9145,186
31 Mar 191,198,93924,200192,2694,919
31 Dec 181,180,22022,345192,9674,179
30 Sep 181,163,67323,471192,4903,200
30 Jun 181,148,40225,169194,4263,221
31 Mar 181,152,53324,153199,7242,307
31 Dec 171,141,56623,196200,5151,513
30 Sep 171,128,69322,482203,338858
30 Jun 171,100,13720,602204,2980
31 Mar 171,076,30626,392199,4170
31 Dec 161,056,42928,063194,6470
30 Sep 161,066,94431,922190,3800
30 Jun 161,076,68133,587187,1100
31 Mar 161,077,61735,062180,1960
31 Dec 15955,45435,015174,1830
30 Sep 15808,36336,695163,7770
30 Jun 15674,91337,955151,7270
31 Mar 15533,99936,215142,4530
31 Dec 14522,27435,044137,4620
30 Sep 14508,92332,721133,3580
30 Jun 14497,11131,688130,1180
31 Mar 14479,96523,047123,9060
31 Dec 13468,38522,037120,3280

Kaliteli Kazançlar: A009290 yüksek düzeyde nakit dışı kazança sahiptir.

Büyüyen Kar Marjı: A009290 'nin mevcut net kar marjları (2.1%) geçen yılın (2.4%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A009290 şirketinin kazancı son 5 yılda yılda 4.1% oranında arttı.

Büyüme Hızlandırma: A009290 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: A009290 geçtiğimiz yıl negatif kazanç büyümesine ( -6.4% ) sahipti ve bu da onu Pharmaceuticals sektör ortalamasıyla ( 21.9% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: A009290 'nin Özsermaye Getirisi ( 5.9% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin